The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite
Abstract
Through this brief review, we provide a comprehensive historical background of the development of nanostructured hydroxyapatite (nHAp), and its application potentials for controlled drug delivery, drug conjugation, and other biomedical treatments. Aspects associated with efficient utilization of hydroxyapatite (HAp) nanostructures such as their synthesis, interaction with drug molecules, and other concerns, which need to be resolved before they could be used as a potential drug carrier in body system, are discussed. This review focuses on the evolution of perceptions, practices, and accomplishments in providing improved delivery systems for drugs until date. The pioneering developments that have presaged today's fascinating state of the art drug delivery systems based on HAp and HAp‐based composite nanostructures are also discussed. Special emphasis has been given to describe the application and effectiveness of modified HAp as drug carrier agent for different diseases such as bone‐related disorders, carriers for antibiotics, anti‐inflammatory, carcinogenic drugs, medical imaging, and protein delivery agents. As only a very few published works made comprehensive evaluation of HAp nanostructures for drug delivery applications, we try to cover the three major areas: concepts, practices and achievements, and applications, which have been consolidated and patented for their practical usage. The review covers a broad spectrum of nHAp and HAp modified inorganic drug carriers, emphasizing some of their specific aspects those needed to be considered for future drug delivery applications. This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease Nanotechnology Approaches to Biology > Cells at the Nanoscale
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Surface Chemistry Influences Implant Biocompatibility
Tang, L., Thevenot, P., & Hu, W. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783790901 · Cited by 800
Cited by
Hydroxyapatite, a multifunctional material for air, water and soil pollution control: A review
Ibrahim, M., Labaki, M., Giraudon, J.-M., & Lamonier, J.-F. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121139 · Cited by 564
Hydroxyapatite: A journey from biomaterials to advanced functional materials
Mondal, S., Park, S., Choi, J., Vu, T. T. H., Doan, V. H. M., Vo, T. T., Lee, B., & Oh, J. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.103013 · Cited by 344
Self-citationMachine Learning‐Driven Biomaterials Evolution
Suwardi, A., Wang, F., Xue, K., Han, M., Teo, P., Wang, P., Wang, S., Liu, Y., Ye, E., Li, Z., et al. (2022) · Advanced Materials · doi:10.1002/adma.202102703 · Cited by 299
Kumar, A., Kargozar, S., Baino, F., & Han, S. S. (2019) · Frontiers in Materials · doi:10.3389/fmats.2019.00313 · Cited by 189
Metadata
- Authors
- Mondal, S., Dorozhkin, S. V., & Pal, U.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2017-11-23
- Volume
- 10
- Issue
- 4
- Pages
- e1504-e1504
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W2768640554
- Cited by
- 218
- References
- 2
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite. https://app.cochat.ai/papers/10.1002/wnan.1504
- The paper
- Mondal, S., Dorozhkin, S. V., & Pal, U. (2018). Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1504
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.